InterCure Ltd.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +220.6% | +104.9% | -204.6% | – | – | |
| – | – | – | – | +187.7% | +130.0% | +14,043.5% | +127.3% | +58.2% | +12.5% | +16.7% | +11.6% | |
| – | – | -91.8% | -74.2% | +112,528.0% | +729.1% | -84.6% | -35.5% | +38.1% | -70.9% | -12.0% | +6.5% | |
| – | – | – | – | +125.2% | -186.2% | – | -68.2% | – | – | – | – | |
| – | -237.0% | – | – | – | -171.9% | – | – | – | – | – | – | |
| – | – | – | +1,108.9% | +0.0% | -98.9% | +2,084,000.0% | -32.7% | +40.7% | -86.7% | +67.1% | -18.9% | |
| – | -1,144.3% | +17.3% | -79.4% | +252.1% | +384.5% | -40.9% | +186.5% | +118.5% | – | +270.6% | -111.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +856.2% | -105.8% | +2,580.6% | – | +109.2% | -145.0% | – | -476.2% | |
| – | +3,671.6% | -7.2% | -76.7% | +271.1% | +523.4% | -61.8% | +682.7% | -39.2% | -168.8% | – | -276.4% | |
| – | – | -94.5% | -396.2% | – | +1,751.3% | -52.0% | +1,400.8% | -77.0% | -461.4% | – | – | |
| – | – | – | – | – | – | – | – | +186.8% | -278.4% | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.